SCHEMBL3959544

SCHEMBL3959544

O=S(=O)(c1ccccc1)c1cc(CNCCc2cccc(Cl)c2)ccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ HDAC1 Q13547 1/20 0.50
▸ CHRM2 P08172 1/20 0.47
▸ AKR1C3 P42330 1/20 0.46
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA12 O43570 1/20 0.45
▸ CA4 P22748 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ HTR6 P50406 2/20 0.45
▸ BCHE P06276 1/20 0.45
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ SLC2A1 P11166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3963736 0.84 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL4232031 0.77 TDP1 (0.51) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL27614794 0.76 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL3959541 0.75 CASR (0.46) KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL14537621 0.75 CASR (0.46) KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL5947765 0.74 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL3958999 0.74 CYP1A2 (0.54) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL3878291 0.73 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL5947247 0.72 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19HDAC1
SCHEMBL228959 0.72 KIF18A (0.57) CYP3A4CYP2C19HTR6ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079525-A1 CALCIUM RECEPTOR MODULATING AGENTS Amgen Inc. (US) 2009-07-22 — — EP claimed
WO-2008057282-A1 CALCIUM RECEPTOR MODULATING AGENTS AMGEN INC. (US) 2008-05-15 — — WO claimed
EP-2079525-A1 CALCIUM RECEPTOR MODULATING AGENTS Amgen Inc. (US) 2009-07-22 — — EP disclosed
WO-2008057282-A1 CALCIUM RECEPTOR MODULATING AGENTS AMGEN INC. (US) 2008-05-15 — — WO disclosed
Send feedback